PIM2 and lymphoma: The use of Pim-1 and Pim-2 expressing lymphoid cells in transgenic mice also causes a low frequency of lymphomas after long latency periods; whereas Pim-3 expressing liver cells of transgenic mice produce carcinomas but only in the presence of carcinogens [18].